Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hossam Nada

Showing results (11-20 of 79) with videos related to

Pageof 8
Sort By:
Computational and Structural Biotechnology Journal|November 24, 2025
Targeting CAPON to modulate the CAPON-NOS Axis: a computational approachHossam Nada, Gerhard Wolber, Moustafa T Gabr
Biorxiv : the Preprint Server for Biology|December 15, 2025
An Integrated Biophysical Fragment Screening Approach Identifies Novel Binders of the CD28 Immune ReceptorLaura Calvo-Barreiro, Hossam Nada, Moustafa Gabr
Archives of Biochemistry and Biophysics|May 20, 2026
First-in-Class Small Molecule ROBO2 Binders Identified through Integrated Virtual Screening and Biophysical ValidationKirti Upmanyu, Hossam Nada, Moustafa T Gabr
Expert Opinion on Drug Discovery|December 6, 2025
Using biophysical techniques to enhance early-stage drug discovery: the impact and challengesNatalie Fuchs, Hossam Nada, Moustafa T Gabr
Biorxiv : the Preprint Server for Biology|November 24, 2025
Identification of a First-In-Class Small Molecule CAPON Binder Using Affinity Selection-Mass Spectrometry ScreeningAshraf N Abdo, Hossam Nada, Moustafa Gabr
Journal of Enzyme Inhibition and Medicinal Chemistry|May 11, 2026
Structural optimization of CHI3L1 inhibitors with improved pharmacokinetics and functional activity in 3D glioblastoma modelsBaljit Kaur, Hossam Nada, Moustafa T Gabr
Expert Opinion on Drug Discovery|January 25, 2025
Virtual screening: hope, hype, and the fine line in betweenHossam Nada, Nicholas A Meanwell, Moustafa T Gabr
Biorxiv : the Preprint Server for Biology|February 6, 2026
Targeting CHI3L1 in Alzheimer's Disease: Optimization of G721-0282 and Functional Evaluation in Astrocyte ModelsBaljit Kaur, Hossam Nada, Longfei Zhang, et al.
Biorxiv : the Preprint Server for Biology|August 6, 2025
Discovery of CD28-Targeted Small Molecule Inhibitors of T Cell Co-stimulation Using Affinity Selection-Mass Spectrometry (AS-MS) and Ex Vivo ValidationSaurabh Upadhyay, Sungwoo Cho, Hossam Nada, et al.
Biochemistry and Biophysics Reports|March 18, 2026
An integrated biophysical fragment screening approach identifies novel binders of the CD28 immune receptorLaura Calvo-Barreiro, Hossam Nada, Moustafa T Gabr
Pageof 8

Showing results (11-20 of 79) with videos related to

Sort By:
Pageof 8
Computational and Structural Biotechnology Journal|November 24, 2025
Targeting CAPON to modulate the CAPON-NOS Axis: a computational approachHossam Nada, Gerhard Wolber, Moustafa T Gabr
Biorxiv : the Preprint Server for Biology|December 15, 2025
An Integrated Biophysical Fragment Screening Approach Identifies Novel Binders of the CD28 Immune ReceptorLaura Calvo-Barreiro, Hossam Nada, Moustafa Gabr
Archives of Biochemistry and Biophysics|May 20, 2026
First-in-Class Small Molecule ROBO2 Binders Identified through Integrated Virtual Screening and Biophysical ValidationKirti Upmanyu, Hossam Nada, Moustafa T Gabr
Expert Opinion on Drug Discovery|December 6, 2025
Using biophysical techniques to enhance early-stage drug discovery: the impact and challengesNatalie Fuchs, Hossam Nada, Moustafa T Gabr
Biorxiv : the Preprint Server for Biology|November 24, 2025
Identification of a First-In-Class Small Molecule CAPON Binder Using Affinity Selection-Mass Spectrometry ScreeningAshraf N Abdo, Hossam Nada, Moustafa Gabr
Journal of Enzyme Inhibition and Medicinal Chemistry|May 11, 2026
Structural optimization of CHI3L1 inhibitors with improved pharmacokinetics and functional activity in 3D glioblastoma modelsBaljit Kaur, Hossam Nada, Moustafa T Gabr
Expert Opinion on Drug Discovery|January 25, 2025
Virtual screening: hope, hype, and the fine line in betweenHossam Nada, Nicholas A Meanwell, Moustafa T Gabr
Biorxiv : the Preprint Server for Biology|February 6, 2026
Targeting CHI3L1 in Alzheimer's Disease: Optimization of G721-0282 and Functional Evaluation in Astrocyte ModelsBaljit Kaur, Hossam Nada, Longfei Zhang, et al.
Biorxiv : the Preprint Server for Biology|August 6, 2025
Discovery of CD28-Targeted Small Molecule Inhibitors of T Cell Co-stimulation Using Affinity Selection-Mass Spectrometry (AS-MS) and Ex Vivo ValidationSaurabh Upadhyay, Sungwoo Cho, Hossam Nada, et al.
Biochemistry and Biophysics Reports|March 18, 2026
An integrated biophysical fragment screening approach identifies novel binders of the CD28 immune receptorLaura Calvo-Barreiro, Hossam Nada, Moustafa T Gabr
Pageof 8